John B. Moriarty, SVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 10,000 shares at $179.00 ($1.8M) on 2014-10-06, disclosed to the SEC on 2014-10-08.
Scheduled sale ($1.8M) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |